Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 May 12;11(5):e0155554.
doi: 10.1371/journal.pone.0155554. eCollection 2016.

Maternal Smoking during Pregnancy and DNA-Methylation in Children at Age 5.5 Years: Epigenome-Wide-Analysis in the European Childhood Obesity Project (CHOP)-Study

Peter Rzehak  1 , Richard Saffery  2 , Eva Reischl  3 , Marcela Covic  1 , Simone Wahl  3 , Veit Grote  1 , Annick Xhonneux  4 , Jean-Paul Langhendries  4 , Natalia Ferre  5 , Ricardo Closa-Monasterolo  5 , Elvira Verduci  6 , Enrica Riva  6 , Piotr Socha  7 , Dariusz Gruszfeld  7 , Berthold Koletzko  1 ; European Childhood Obesity Trial Study group
Affiliations

Maternal Smoking during Pregnancy and DNA-Methylation in Children at Age 5.5 Years: Epigenome-Wide-Analysis in the European Childhood Obesity Project (CHOP)-Study

Peter Rzehak et al. PLoS One. .

Abstract

Mounting evidence links prenatal exposure to maternal tobacco smoking with disruption of DNA methylation (DNAm) profile in the blood of infants. However, data on the postnatal stability of such DNAm signatures in childhood, as assessed by Epigenome Wide Association Studies (EWAS), are scarce. Objectives of this study were to investigate DNAm signatures associated with in utero tobacco smoke exposure beyond the 12th week of gestation in whole blood of children at age 5.5 years, to replicate previous findings in young European and American children and to assess their biological role by exploring databases and enrichment analysis. DNA methylation was measured in blood of 366 children of the multicentre European Childhood Obesity Project Study using the Illumina Infinium HM450 Beadchip (HM450K). An EWAS was conducted using linear regression of methylation values at each CpG site against in utero smoke exposure, adjusted for study characteristics, biological and technical effects. Methylation levels at five HM450K probes in MYO1G (cg12803068, cg22132788, cg19089201), CNTNAP2 (cg25949550), and FRMD4A (cg11813497) showed differential methylation that reached epigenome-wide significance according to the false-discovery-rate (FDR) criteria (q-value<0.05). Whereas cg25949550 showed decreased methylation (-2% DNAm ß-value), increased methylation was observed for the other probes (9%: cg12803068; 5%: cg22132788; 4%: cg19089201 and 4%: cg11813497) in exposed relative to non-exposed subjects. This study thus replicates previous findings in children ages 3 to 5, 7 and 17 and confirms the postnatal stability of MYO1G, CNTNAP2 and FRMD4A differential methylation. The role of this differential methylation in mediating childhood phenotypes, previously associated with maternal smoking, requires further investigation.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1
Volcano plot (A) and QQ-plot (B) of 433 313 differentially methylated CpG sites for 366 children at age 5.5 exposed vs. not-exposed to maternal smoking beyond week 12 of gestation. Figures are based on linear regression of M-values on exposure variable and adjustment factors.
Fig 2
Fig 2
Regional association of CpG methylation at MYO1G (A), CNTNAP2 (B) and FRMD4A (C) loci with prenatal smoking status. The direction of differential methylation is marked with arrows (↑ increase or ↓ decrease). Regional association plots are shown using the gene map (UCSC genome browser, hg19) with a graph of–log10 p-values on the y-axis, the nucleotide position on the x-axis, and the position of selected Illumina Infinium HumanMethylation 450 BeadChip probes. Abbreviations: CGI: CpG island; TSS: transcription start site; FDR: false discovery rate p-value.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Novakovic B, Ryan J, Pereira N, Boughton B, Craig JM, et al. (2014) Postnatal stability, tissue, and time specific effects of AHRR methylation change in response to maternal smoking in pregnancy. Epigenetics 9: 377–386. 10.4161/epi.27248 - DOI - PMC - PubMed
    1. Joubert BR, Haberg SE, Nilsen RM, Wang X, Vollset SE, et al. (2012) 450K epigenome-wide scan identifies differential DNA methylation in newborns related to maternal smoking during pregnancy. Environ Health Perspect 120: 1425–1431. 10.1289/ehp.1205412 - DOI - PMC - PubMed
    1. Markunas CA, Xu Z, Harlid S, Wade PA, Lie RT, et al. (2014) Identification of DNA methylation changes in newborns related to maternal smoking during pregnancy. Environ Health Perspect 122: 1147–1153. 10.1289/ehp.1307892 - DOI - PMC - PubMed
    1. Ivorra C, Fraga MF, Bayon GF, Fernandez AF, Garcia-Vicent C, et al. (2015) DNA methylation patterns in newborns exposed to tobacco in utero. J Transl Med 13: 25 10.1186/s12967-015-0384-5 - DOI - PMC - PubMed
    1. Kupers LK, Xu X, Jankipersadsing SA, Vaez A, la Bastide-van Gemert S, et al. (2015) DNA methylation mediates the effect of maternal smoking during pregnancy on birthweight of the offspring. Int J Epidemiol. - PMC - PubMed

Publication types

Grants and funding

The studies and research reported herein were partially supported by the Commission of the European Community, specific RTD Programme “Quality of Life and Management of Living Resources,” within the 5th Framework Programme (research grant nos. QLRT-2001-00389 and QLK1-CT-2002-30582); the 6th Framework Programme (contract no. 007036); the European Union’s Seventh Framework Programme (FP7/2007-2013), project EarlyNutrition under grant agreement no. 289346 and the European Research Council Advanced Grant ERC-2012-AdG – no.322605 META-GROWTH. This manuscript does not necessarily reflect the views of the Commission and in no way anticipates the future policy in this area. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.